198 related articles for article (PubMed ID: 32002622)
1. Fatal Lung Toxicity After Intralesional Bleomycin Sclerotherapy of a Vascular Malformation.
Cho AL; Kiang SC; Lodenkamp J; Tritch WTH; Tomihama RT
Cardiovasc Intervent Radiol; 2020 Apr; 43(4):648-651. PubMed ID: 32002622
[TBL] [Abstract][Full Text] [Related]
2. Acute Lung Toxicity After Intralesional Bleomycin Sclerotherapy.
Méndez-Echevarría A; Fernandez-Prieto A; de la Serna O; Lopez-Gutierrez JC; Parron M; Marin-Aguilera B; Calvo C
Pediatrics; 2018 Jan; 141(1):. PubMed ID: 29269387
[TBL] [Abstract][Full Text] [Related]
3. Intralesional bleomycin injection in management of low flow vascular malformations in children.
Mohan AT; Adams S; Adams K; Hudson DA
J Plast Surg Hand Surg; 2015 Apr; 49(2):116-20. PubMed ID: 25204206
[TBL] [Abstract][Full Text] [Related]
4. Acute pulmonary toxicity following intralesional administration of bleomycin for a lymphovenous malformation.
Atwa K; Abuhasna S; Shihab Z; Hashaykeh N; Hasan R
Pediatr Pulmonol; 2010 Feb; 45(2):192-6. PubMed ID: 19953580
[TBL] [Abstract][Full Text] [Related]
5. Single center experience with intralesional bleomycin sclerotherapy for lymphatic malformations.
Yılmaz H; Yılmaz Ö; Çamlıdağ İ; Belet Ü; Akan H
Jpn J Radiol; 2017 Oct; 35(10):590-596. PubMed ID: 28779454
[TBL] [Abstract][Full Text] [Related]
6. Role of intralesional bleomycin sclerotherapy as the sole or adjunct treatment of superficial ocular adnexal lymphatic malformations.
Bothra N; Panda L; Sheth J; Tripathy D
Eye (Lond); 2018 Jan; 32(1):152-155. PubMed ID: 28776595
[TBL] [Abstract][Full Text] [Related]
7. Bleomycin sclerotherapy for extensive lympho-venous malformation. a retrospective analysis of a patient's death.
Kantorowicz S; Kobylarz K; Wojciechowski P
Eur J Pediatr Surg; 2011 Mar; 21(2):134-6. PubMed ID: 20669095
[No Abstract] [Full Text] [Related]
8. Image-Guided Percutaneous Bleomycin and Bevacizumab Sclerotherapy of Orbital Lymphatic Malformations in Children.
Abdelaziz O; Hassan F; Elessawy K; Emad-Eldin S; Essawy RE
Cardiovasc Intervent Radiol; 2019 Mar; 42(3):433-440. PubMed ID: 30488306
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous sclerotherapy of massive macrocystic lymphatic malformations of the face and neck using fibrin glue with OK-432 and bleomycin.
Chen WL; Huang ZQ; Chai Q; Zhang DM; Wang YY; Wang HJ; Wang L; Fan S
Int J Oral Maxillofac Surg; 2011 Jun; 40(6):572-6. PubMed ID: 21367582
[TBL] [Abstract][Full Text] [Related]
10. Lymphatic malformations compromising the upper airway in children: ultrasound-guided intralesional focal sclerotherapy with bleomycin targeting culprit lesions.
Usui H; Shinkai M; Kitagawa N; Mochizuki K; Kawakita I; Tsuzuki Y; Shinohara S; Yagi Y; Masuda M
Pediatr Surg Int; 2020 Sep; 36(9):1047-1054. PubMed ID: 32661596
[TBL] [Abstract][Full Text] [Related]
11. Use of percutaneous bleomycin sclerotherapy for orbital lymphatic malformations.
Hanif AM; Saunders JA; Hawkins CM; Wojno TH; Kim HJ
Orbit; 2019 Feb; 38(1):30-36. PubMed ID: 29902086
[TBL] [Abstract][Full Text] [Related]
12. Bleomycin electrosclerotherapy: new treatment to manage vascular malformations.
McMorrow L; Shaikh M; Kessell G; Muir T
Br J Oral Maxillofac Surg; 2017 Nov; 55(9):977-979. PubMed ID: 29055573
[TBL] [Abstract][Full Text] [Related]
13. Noninvasive management of hemangioma and vascular malformation using intralesional bleomycin injection.
Hassan Y; Osman AK; Altyeb A
Ann Plast Surg; 2013 Jan; 70(1):70-3. PubMed ID: 23249476
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of bleomycin sclerotherapy for microcystic lymphatic malformation.
Chaudry G; Guevara CJ; Rialon KL; Kerr C; Mulliken JB; Greene AK; Fishman SJ; Boyer D; Alomari AI
Cardiovasc Intervent Radiol; 2014 Dec; 37(6):1476-81. PubMed ID: 24938907
[TBL] [Abstract][Full Text] [Related]
15. Sclerotherapy with bleomycin does not adversely affect facial nerve function in children with cervicofacial cystic lymphatic malformation.
Karavelioğlu A; Temuçin CM; Tanyel FC; Ciftci AO; Senocak ME; Karnak I
J Pediatr Surg; 2010 Aug; 45(8):1627-32. PubMed ID: 20713211
[TBL] [Abstract][Full Text] [Related]
16. Bleomycin A5 sclerotherapy for cervicofacial lymphatic malformations.
Yang Y; Sun M; Ma Q; Cheng X; Ao J; Tian L; Wang L; Lei D
J Vasc Surg; 2011 Jan; 53(1):150-5. PubMed ID: 20843632
[TBL] [Abstract][Full Text] [Related]
17. Management of periorbital microcystic lymphatic malformation with blepharoptosis: Surgical treatment combined with intralesional bleomycin injection.
Yang X; Jin Y; Lin X; Chen H; Ma G; Hu X; Qiu Y; Yu W; Chang L; Wang T
J Pediatr Surg; 2015 Aug; 50(8):1393-7. PubMed ID: 25783292
[TBL] [Abstract][Full Text] [Related]
18. Efficacy Of Intralesional Bleomycin Injection Sclerotherapy In Macrocystic Lymphangioma In Paediatric Patients.
Muhammad Khuzaemah Saalim Hashmi SA; Hussain M; Ahmad S; Gillani K
J Ayub Med Coll Abbottabad; 2020; 32(1):42-45. PubMed ID: 32468753
[TBL] [Abstract][Full Text] [Related]
19. Treatment of deep-seated facial microcystic lymphatic malformations with intralesional injection of pingyangmycin.
Wu HW; Wang X; Zheng JW; Zhao HG; Ge J; Zhang L; Wang YA; Su LX; Fan XD
Medicine (Baltimore); 2016 Sep; 95(37):e4790. PubMed ID: 27631231
[TBL] [Abstract][Full Text] [Related]
20. Preliminary experience of percutaneous intralesional bleomycin injection for the treatment of orbital lymphatic-venous malformation refractory to surgery.
Shen CY; Wu MC; Tyan YS; Ou CH; Chen TY; Wong HF
Clin Radiol; 2012 Feb; 67(2):182-4. PubMed ID: 22018802
[No Abstract] [Full Text] [Related]
[Next] [New Search]
